EVALUATION OF PRICE DISPARITY AMONG GENERIC MEDICINES IN INDIA

Authors

  • Reena Shaik Department of Pharmacy Management, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal - 576 104, Karnataka, India.
  • Pradeep M Muragundi Department of Pharmacy Management, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal - 576 104, Karnataka, India. http://orcid.org/0000-0003-4897-6187

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i12.28461

Keywords:

Generic medicine Price, Central government health scheme, Jan aushadhi, India

Abstract

Objective: Even though the generic medicines are considered to be a cheaper option compared to the branded medicines in India, there is a need to study the price disparity among the generic medicines. Hence, the present study aims to evaluate the price disparity in generic medicines under Government Scheme in India.

Methods: It was found that there were 101 generic medicines approved at a fixed price for procurement under the Central Government Health Services scheme. The prices of these medicines were searched for their availability as well as for current price in Bureau of Pharma PSUs of India (under Jan Aushadhi scheme) website.

Results: The major category of the generic medicine were antibiotics (53.45%) followed by nonsteroidal anti-inflammatory drugs (10.89%) and cardiovascular (6.93%) drugs. It was evident from the result obtained by comparing the prices across categories that there were both positive and negative deviations.

Conclusion: It was very much evident from the results of the mean of differences that even though fixed price contracts being in place, there is a price disparity in the generic drug prices seen under Government Scheme.

Downloads

Download data is not yet available.

Author Biographies

Reena Shaik, Department of Pharmacy Management, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal - 576 104, Karnataka, India.

PG Student, Department of Pharmacy Management

Pradeep M Muragundi, Department of Pharmacy Management, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal - 576 104, Karnataka, India.

Associate Professor

Deprtment of Pharmacy Management

References

Atal S, Atal S, Deshmankar B, Nawaz SA. Cost analysis of commonly used drugs under price control in India: Assessing the effect of drug price control order on brand price variation. Int J Pharm Pharm Sci 2016;8:315-21.

Mukherjee K. A cost analysis of the jan aushadhi scheme in India. Int J Health Policy Manag 2017;6:253-6.

Priya D, Purohit S, Pandey BL. Drug utilization study and evaluation of anti-hypertensive prescriptions from medical reimbursement applications at university health care facility, BHU, Varanasi. Int J Pharm Pharm Sci 2015;7:283-6.

Singhal GL, Anita K, Nanda A. Jan aushadhi stores in India and quality of medicines therein. Int J Pharm Pharm Sci 2011;3:204-7.

Ahire K, Shukla M, Gattani M, Singh V, Singh M. A survey based study in current scenario of generic and branded medicines. Int J Pharm Pharm Sci 2013;5:705-11.

Nagappa AN, Chikkamath V. Pradhan Mantari Jan Aushadi Kendra- Demonetarization of Medicine Prices in India. Vol. 4; 2016. Available from: https://www.omicsonline.org/open-access/pradhan-mantari-jan-aushadi-kendra--demonetarization-of-medicine-prices-in-india-2329-9126-1000281.pdf.

Gupta S, Nayak R, Vidyarthi S. A study on the knowledge, attitude, and the practice of generic medicines among the doctors in a tertiary care teaching hospital in South India. Natl J Physiol Pharm Pharm 2015;5:39.

Bureau of Pharma PSUs of India (BPPI), Government of India; 2017. Available from: http://www.janaushadhi.gov.in/ProductList.aspx. [Last cited on 2018 Feb 04].

Medical Stores Organization, Ministry of Health and Family Welfare, Government of India. Available from: http://www.mso.gov.in. [Last cited on 2018 Feb 04].

Published

07-12-2018

How to Cite

Shaik, R., and P. M Muragundi. “EVALUATION OF PRICE DISPARITY AMONG GENERIC MEDICINES IN INDIA”. Asian Journal of Pharmaceutical and Clinical Research, vol. 11, no. 12, Dec. 2018, pp. 466-8, doi:10.22159/ajpcr.2018.v11i12.28461.

Issue

Section

Original Article(s)